Concepedia

Sue Stephens

SS

32

Publications

4.2K

Citations

26

H-Index

1990

Active since

Affiliations

UCB Pharma (United Kingdom)(Current)

St Bartholomew's Hospital

CTI BioPharma (United Kingdom)

University of Liverpool

University of California, Los Angeles

Sue Stephens is an author at UCB Pharma (United Kingdom) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1990–2017

32

Publications

32

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

Christian Braegger, Stephen J. Nicholls, Simon Murch et al. · The Lancet · 1992 · 694 citations

, , +9

Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents

Andrew Nesbitt, Gianluca Fossati, Marianne Bergin et al. · Inflammatory Bowel Diseases · 2007 · 465 citations

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

Charles J. Fisher, Steven M. Opal, Jean-François Dhainaut et al. · Critical Care Medicine · 1993 · 431 citations

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 354 citations · Full text

Significance of systemic endotoxaemia in inflammatory bowel disease.

Keith Gardiner, M I Halliday, G R Barclay et al. · Gut · 1995 · 232 citations · Full text

Rows per page

1–5 of 32